ROP
62
3
NWL
53
3
SLB
55
2
CRM
67
2
IR
66
3
DD
63
3
EOG
58
2
MLM
57
6
INTU
56
-4
ADSK
70
2
FE
50
-2
MCD
52
2
CINF
53
2
EXC
53
-3
COF
60
2
LRCX
43
-2
CCI
31
3
RHI
59
2
TGT
22
2
ACN
52
3
ROP
62
3
NWL
53
3
SLB
55
2
CRM
67
2
IR
66
3
DD
63
3
EOG
58
2
MLM
57
6
INTU
56
-4
ADSK
70
2
FE
50
-2
MCD
52
2
CINF
53
2
EXC
53
-3
COF
60
2
LRCX
43
-2
CCI
31
3
RHI
59
2
TGT
22
2
ACN
52
3
Financhill
Back

GlycoMimetics 10K Form

Sell
47

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
11.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q GLYC/GlycoMimetics Quarterly
2023-11-03 10Q GLYC/GlycoMimetics Quarterly
2023-08-02 10Q GLYC/GlycoMimetics Quarterly
2023-05-03 10Q GLYC/GlycoMimetics Quarterly
2022-11-09 10Q GLYC/GlycoMimetics Quarterly
2022-08-03 10Q GLYC/GlycoMimetics Quarterly

Receive GLYC News And Ratings

See the #1 stock for the next 7 days that we like better than GLYC

GLYC Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-7.99M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 1.8

Profitability

EPS (TTM): -0.62000
Net Income (TTM): $-39.74M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

GlycoMimetics Earnings Forecast

Key GlycoMimetics Financial Ratios

  • The Gross Profit Margin over the past 4 years for GLYC is 0.00%.
  • The Selling, General & Administrative Expenses for GLYC have been equal to 192,130.00% of Gross Profit Margin.
  • The Research & Development expenses have been 200,716.60% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of GLYC is -368,994.20% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

GlycoMimetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLYC
CUSIP: 38000Q
Website: glycomimetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GLYC Technical Analysis vs Fundamental Analysis

Sell
47
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy or a Sell?

  • GlycoMimetics stock is rated a Sell
    The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.